Natco Pharma Ltd

BSE: 524816

45

total announcements

NATCOPHARM.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 19 Nov 2026

Market Cap

₹16,098 Cr

P/E (TTM)

17.9

P/E (Forward)

17.5

EPS (TTM)

₹45.89

52W Low

₹773.60

52W High

₹1,226.80

Dividend Yield

0.54%

Beta

0.18

Price / Book

1.5

Return on Equity

9.01%

Debt / Equity

10.6

Revenue (TTM)

₹3,092 Cr

Gross Margin

78.56%

Operating Margin

18.32%

BSEBoard Meeting▲ PositiveResults14 Aug 2026

Natco Pharma Ltd

Outcome of Board Meeting

Natco Pharma Ltd announced unaudited financial results for Q1 FY27, with consolidated revenue of ₹794.4 Crore and profit after tax of ₹206.5 Crore. The company declared an interim dividend of ₹1.5 per equity share. The Board also approved the reconstitution of Risk Management Committee and Environment, Social and Governance Committee.

Read more →📎 1 attachment
BSEBoard MeetingFundraise11 Aug 2026

Natco Pharma Ltd

Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Further to our earlier intimation ....

Natco Pharma Ltd has informed BSE that the company's Board of Directors will meet on August 14, 2026 to consider raising funds through various methods, including public issue, preferential issue, rights issue, and private placement.

Read more →📎 1 attachment
← PreviousPage 3 of 3